Uncertainty in dose estimation for gynecological implants.
One source of uncertainty in doses computed for intracavitary gynecological applications is the imprecision inherent in localizing the sources and the points of interest on radiographs of the implant and in transferring that data into the treatment planning computer. To quantify the effect of these activities on the accuracy of computed doses, five physicists and two dosimetrists performed computerized dose calculations on five applications chosen randomly from our patient files. For each of these applications, doses were computed at the traditional points A and B and at points in the bladder and rectum. Using identical sets of films, each planner located both the radioactive sources and points of interest, or only the sources, or only the points of interest. Another set of films was used to measure the accuracy of digitizing alone. Planners received no instructions on either the definition or the placement of the points of interest. Overall uncertainties in computed doses to points A and B and bladder were found to be about 7%. Uncertainty in dose to the rectum was on the order of 50%. Analysis of the results showed that about 1% of the error was due to digitization and about 2% to identification of source locations. Among the individual planners, almost all of the dose variation was from differences in placement of the points of interest on the implant radiographs. The results demonstrate the need for standard definitions and locations for points of calculation so that meaningful comparisons can be made among institutions.
Chow
H
H
Department of Radiation Therapy, University of Texas Medical Branch, Galveston 77550.
Lane
R G
RG
Rosen
I I
II
D001918:Brachytherapy; D005260:Female; D005833:Genital Neoplasms, Female / Q000532:radiotherapy*; D006801:Humans; D011879:Radiotherapy Dosage; D012007:Rectum / Q000528:radiation effects; D001743:Urinary Bladder / Q000528:radiation effects